Alzamend Neuro: Ascendiant Capital lowers PT to $45, maintains Buy rating.

jueves, 21 de agosto de 2025, 6:01 am ET1 min de lectura
ALZN--

Alzamend Neuro: Ascendiant Capital lowers PT to $45, maintains Buy rating.

Alzamend Neuro: Ascendiant Capital lowers PT to $45, maintains Buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios